Arteriocyte Medical Systems Focused on Improving Surgical Outcomes 
Corporate Homepage

Cleveland, OH, July 20, 2011 - Arteriocyte receives $1 Million award from Ohio Third Frontier Program to advance its NANEX™ technology toward clinical use. read more ...

Cleveland, OH, June 7, 2011 - Arteriocyte and the US Army Institute of Surgical Research (USAISR) sign a CRADA to speed development of Cellular Therapies for Orthopaedic Trauma. read more ...

Cleveland, OH, January 28, 2011 - Arteriocyte announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia (CLI). read more ...

Cleveland, OH, May 20, 2009 - Arteriocyte Medical Systems announced today a strategic investment in Control Medical Technology, a medical device developer based in Park City, Utah. read more ...

Thursday, November 08, 2007 - Arteriocyte Medical Systems Forms Strategic Partnership with Medtronic including Acquisition of the Magellan Platelet Rich Plasma Business.  read more ...

Thursday, October 25, 2007 - Arteriocyte, Inc. and DW Healthcare Partners, today announced the formation of Arteriocyte Medical Systems, Inc., launching the company with a $10 million growth capital investment.  read more ...

 


  Customer Service

  For information or to
  place an order please call:
  1-866-660-AMSI(2674)
  or 1-508-497-8951(fax)
 

  Locations:
 
  Ohio Offices

  Cleveland
  Research & Development Center
  7100 Euclid Avenue
  Cleveland, Ohio 44103, USA
  Phone: 216-456-9640
 
  Massachusetts Offices

  Hopkinton
  Manufacturing & Distribution Cntr
  45 South Street
  Hopkinton, MA 01748, USA
  Phone: 508-497-8950

  Minnesota Offices

  Minneapolis
  Technology Innovation Center
  14156 Northdale Blvd.
  Rogers, MN 55374, USA

  Utah Offices

  Park City
  Tissue Engineering Center
  1413 Center Drive, Ste 220
  Park City, UT 84098, USA

  E-mail: info@arteriocyte.com
  Phone: 1-866-660-AMSI(2674)
  Fax: 1-508-497-8951